Patent details

EP2804863 Title: NEW FORMS AND SALTS OF A DIHYDROPYRROLOÖ1,2-CÜIMIDAZOLYL ALDOSTERONE SYNTHASE OR AROMATASE INHIBITOR

Basic Information

Publication number:
EP2804863
PCT Application Number:
PCT/US/2013/021521
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137011946
PCT Publication Number:
WO/2013/109514
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NEW FORMS AND SALTS OF A DIHYDROPYRROLOÖ1,2-CÜIMIDAZOLYL ALDOSTERONE SYNTHASE OR AROMATASE INHIBITOR
French Title of Invention:
NOUVELLES FORMES ET SELS D'UN INHIBITEUR DE L'ALDOSTÉRONE SYNTHASE IMIDAZOLE DIHYDROPYRROLO Ö1,2-CÜOU OU DE L'INHIBITEUR DE L'AROMATASE
German Title of Invention:
NEUE FORMEN UND SALZE EINES DIHYDROPYRROL-Ö1,2-C-ÜIMIDAZOLYL-ALDOSTERON-SYNTHASE- ODER AROMATASEHEMMERS
SPC Number:

Dates

Filing date:
15/01/2013
Grant date:
02/12/2015
EP Publication Date:
02/12/2015
PCT Publication Date:
25/07/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/11/2014
EP B1 Publication Date:
02/12/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/01/2019
Expiration date:
15/01/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/01/2013
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
SUTTON Paul
Address:
United States (US)

2

Name:
LOESER Eric
Address:
United States (US)

Priority

Priority Number:
201261587280
Priority Date:
17/01/2012
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 487/04;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
28/12/2017
Last Annual Fee Paid Number:
6
Last Annual Fee Paid Amount:
66 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
31/05/2019 Outgoing Correspondence 1